查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1777252

肽化妝品用API的全球市場:供給來源·用途·終端用戶產業·各地區 (～2035年)

Global Peptide Cosmetic API Research Report by Source, by Application, by End-Use Industry, by Region Market Forecast till 2035
出版日期: | 出版商: Market Research Future | 英文 169 Pages | 訂單完成後即時交付

價格

全球肽化妝品原料藥 (API) 市場預計將從 2024 年的 9.213 億美元成長至 2035 年的 29.684 億美元，複合年增長率為 11.2%。

全球肽化妝品原料藥 (API) 市場正經歷強勁成長，這主要得益於消費者對天然和有機美容解決方案日益增長的需求。人們對皮膚安全和永續性的認識不斷提高，促使人們關注符合清潔美容標準的肽產品。肽合成技術的快速進步使得能夠創造出更穩定、更有效的化妝品配方。此外，針對特定皮膚問題的個人化護膚需求日益增長，也推動了可客製化肽類產品的使用。皮膚病學研究的進展為肽類護膚品的有效性提供了越來越多的科學證據，進一步加速了市場應用。

然而，市場仍面臨諸多障礙。高昂的合成和配方成本、產品穩定性和遞送機制方面的課題，以及可能延遲產品核准的複雜監管流程，都是限制因素。來自替代活性成分的競爭也是一個限制因素。

儘管面臨這些課題，但成長前景依然強勁，尤其是在生物工程肽、人工智慧護膚品、男士專用抗衰老產品、多步驟護膚程序以及肽研究創新等領域。

區域分析

北美引領全球肽化妝品原料藥市場。這得益於市場對肽化妝品原料藥功能性和抗衰老功效的濃厚興趣、消費者的廣泛認可以及成熟護膚品牌的湧現。此外，先進的研究基礎和對基於科學的高端產品的偏好也推動著市場的成長。

歐洲也是一個重要的市場。對純淨美容的需求、嚴格的成分監管以及德國、法國和英國蓬勃發展的抗衰老市場，正在支撐市場的成長。

在亞太地區，韓妝和日妝的影響力、快速的城市化進程以及偏愛多功能護膚品的年輕群體，正在推動中國、日本、韓國等國的市場快速增長。

本報告探討了全球肽類化妝品原料藥市場，並提供了市場定義和概述、影響市場成長的各種因素分析、市場規模趨勢和預測、按細分市場、地區和主要國家/地區進行的細分、競爭格局以及主要公司的概況。

目錄

第1章 摘要整理

第2章 市場概要

第3章 調查手法

第4章 市場動態

  • 促進因素
    • 對天然和有機化妝品的需求不斷增長
    • 肽合成技術的進步
    • 對個人化護膚解決方案的興趣日益濃厚
    • 肽在皮膚科功效方面的研究不斷擴展
  • 限制因素
    • 肽合成和配方成本高昂
    • 穩定性與遞送課題
    • 監理複雜性和審批延遲
    • 來自替代活性成分的競爭
  • 機遇
    • 清潔美容中的生物工程肽
    • 人工智慧驅動的個人化護膚
    • 多步驟護膚中的肽
    • 男士美容和抗衰老解決方案
    • 肽研究的創新
  • COVID-19影響分析

第5章 市場要素分析

  • 供應鏈分析
  • 波特的五力分析

第6章 肽化妝品用API市場:各用途

  • 抗老化和減少皺紋
  • 皮膚修復與再生
  • 保濕和補水
  • 美白和亮澤
  • 頭髮護理
  • 抗發炎舒緩

第7章 肽化妝品用API市場:不同供應商

  • 植物來源肽
  • 動物原來肽
  • 生物工程肽
  • 化學合成

第8章 肽化妝品用API市場:各終端用戶產業

  • 護膚
  • 護髮
  • 注射型化妝品
  • 其他

第9章 肽化妝品用API市場:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 俄羅斯
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 馬來西亞
    • 泰國
    • 印尼
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • MEA
    • GCC各國
    • 南非
    • 其他

第10章 競爭情形

  • 市場佔有率分析
  • 競爭儀表板

第11章 企業簡介

  • DSM-FIRMENICH
  • BACHEM
  • LIPOTRUE SCIENCE
  • CRODA
  • CAREGEN
  • BASF SE
  • EVONIK INDUSTRIES AG
  • GIVAUDAN ACTIVE BEAUTY
  • ASHLAND GLOBAL HOLDINGS
  • SYMRISE AG
  • PROVITAL GROUP
  • SPEC-CHEM INDUSTRY INC
  • AMBIOPHARM
  • LIPOTEC
  • USV PRIVATE LIMITED
  • CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH(CLR)
  • ACTIVE PEPTIDE COMPANY
  • SEIWA KASEI CO., LTD
  • RS SYNTHESIS
  • BCN PEPTIDES
Product Code: MRFR/HC/38117-HCR

Global Peptide Cosmetic API Research Report by Source (Plant-Derived Peptides, Animal-Derived Peptides, Bioengineered Peptides, Chemically Synthesized), by Application (Anti-Aging & Wrinkle Reduction, Skin Repair & Regeneration, Moisturizing & Hydration, Whitening & Brightening, Hair Care, Anti-Inflammatory & Soothing), by End-Use Industry (Skincare, Haircare, Injectable Cosmetics, Others), by Region (North America, Europe, APAC, South America, MEA) Market Forecast till 2035

Industry Overview

The global peptide cosmetic API market is expected to achieve from its 2024 estimate of USD 921.3 million to USD 2,968.4 million by 2035 at a compound annual growth rate (CAGR) of 11.2%.

Global peptide cosmetic API market is witnessing robust growth, largely fueled by increasing consumer demand for natural and organic beauty solutions. As people become more conscious of skin safety and sustainability, they are turning to peptide-based products that align with clean beauty standards. Rapid technological progress in peptide synthesis has enabled the creation of more stable and effective cosmetic formulations. Moreover, the rising inclination toward personalized skincare regimens has boosted the use of peptides, which can be customized for targeted skin concerns. Expanding dermatological research continues to validate the efficacy of peptides in skincare, further promoting their market adoption.

Nevertheless, the market does encounter several barriers. These include the high cost of synthesis and formulation, challenges in product stability and delivery mechanisms, and complex regulatory processes that can delay product approvals. Competition from alternative active ingredients also poses limitations.

Despite these challenges, growth prospects remain strong, especially in areas like bioengineered peptides, AI-driven skincare, male-focused anti-aging products, multi-step skincare routines, and peptide research innovations.

Industry Segmentations

Based on the application category, the global market is included anti-aging & wrinkle reduction, skin repair & regeneration, moisturizing & hydration, whitening & brightening, hair care, anti-inflammatory & soothing.

Chemically synthesized, plant-derived, animal-derived, and bioengineered peptides are all included in the global peptide cosmetic API market, which is divided by source type.

In terms of end-use variation, the global market is segmented into Skincare, haircare, injectable cosmetics, and others.

Regional Analysis

The global peptide cosmetic API market sees North America leading, thanks to widespread awareness, established skincare brands, and strong interest in functional, anti-aging solutions. Advanced research infrastructure and preference for premium, science-led products are key growth enablers.

Europe is a significant player as well, shaped by clean beauty demand, robust ingredient regulations, and a thriving anti-aging sector in Germany, France, and the UK.

Asia-Pacific is experiencing rapid growth, influenced by K-beauty and J-beauty, surging urbanization, and a young population inclined toward multifunctional skincare in China, Japan, and South Korea.

Latin America is gaining traction, primarily due to Brazil's expanding market for natural and anti-aging cosmetics.

Meanwhile, growth in the Middle East & Africa remains moderate but promising, supported by increasing disposable income and urban expansion.

Key Players

Key competitors of global peptide cosmetic API research report are Chemisches Laboratorium Dr. Kurt Richter GmbH, DSM-Firmenich, Provital Group, Bachem, Lipotrue Science, Croda, Caregen, BASF SE, Evonik Industries AG, Givaudan Active Beauty, Ashland Global Holdings, Symrise AG, Spec-Chem Industry Inc, Ambiopharm, Lipotec, USV Private Limited, Active Peptide Company, Seiwa Kasei Co. Ltd., RS Synthesis, BCN Peptides.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
    • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
    • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
  • 3.6 APPROACHES FOR MARKET END USER ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
    • 3.6.2 DATA FORECASTING
    • 3.6.3 DATA FORECASTING TECHNIQUE
  • 3.7 DATA MODELING
    • 3.7.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.7.2 DATA MODELING:
  • 3.8 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 INCREASING DEMAND FOR NATURAL AND ORGANIC COSMETICS
    • 4.2.2 TECHNOLOGICAL ADVANCEMENTS IN PEPTIDE SYNTHESIS
    • 4.2.3 GROWING PREFERENCE FOR PERSONALIZED SKINCARE SOLUTIONS
    • 4.2.4 EXPANDING RESEARCH ON PEPTIDE BENEFITS IN DERMATOLOGY
  • 4.3 RESTRAINTS
    • 4.3.1 HIGH COST OF PEPTIDE SYNTHESIS AND FORMULATION
    • 4.3.2 STABILITY AND DELIVERY CHALLENGES
    • 4.3.3 REGULATORY COMPLEXITIES AND APPROVAL DELAYS
    • 4.3.4 COMPETITION FROM ALTERNATIVE ACTIVE INGREDIENTS
  • 4.4 OPPORTUNITY
    • 4.4.1 BIOENGINEERED PEPTIDES IN CLEAN BEAUTY
    • 4.4.2 AI-DRIVEN PERSONALIZED SKINCARE
    • 4.4.3 PEPTIDES IN MULTI-STEP SKINCARE REGIMENS
    • 4.4.4 MEN'S GROOMING AND ANTI-AGING SOLUTIONS
    • 4.4.5 INNOVATIONS IN PEPTIDE RESEARCH
  • 4.5 IMPACT ANALYSIS OF COVID - 19
    • 4.5.1 IMPACT 0N OVERALL HEALTHCARE.
    • 4.5.2 ECONOMIC IMPACT.
    • 4.5.3 IMPACT ON GLOBAL PEPTIDE COSMETIC API MARKET MARKET.
    • 4.5.4 IMPACT ON SUPPLY CHAIN OF PEPTIDE COSMETIC API MARKET
    • 4.5.5 PRICE VARIATION OF KEY RAW MATERIALS.
    • 4.5.6 PRODUCTION SHUTDOWN.
    • 4.5.7 CASH FLOW CONSTRAINTS.
    • 4.5.8 IMPACT ON IMPORT/EXPORT.
    • 4.5.9 IMPACT ON MARKET DEMAND OF PEPTIDE COSMETIC API MARKET.
    • 4.5.10 IMPACT DUE TO RESTRICTIONS/LOCKDOWN.
    • 4.5.11 CONSUMER SENTIMENTS.
    • 4.5.12 IMPACT ON PRICING OF PEPTIDE COSMETIC API MARKET.

5 MARKET FACTOR ANALYSIS

  • 5.1 SUPPLY CHAIN ANALYSIS
    • 5.1.1 RAW MATERIAL PROCUREMENT
    • 5.1.2 MANUFACTURING & SYNTHESIS
    • 5.1.3 PACKAGING AND STORAGE
    • 5.1.4 DISTRIBUTION & LOGISTICS
    • 5.1.5 END-USERS & CONSUMER DELIVERY
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 BARGAINING POWER OF SUPPLIERS
    • 5.2.2 BARGAINING POWER OF BUYERS
    • 5.2.3 THREAT OF NEW ENTRANTS
    • 5.2.4 THREAT OF SUBSTITUTES
    • 5.2.5 INTENSITY OF RIVALRY

6 PEPTIDE COSMETIC API MARKET, BY APPLICATION

  • 6.1 INTRODUCTION
  • 6.2 ANTI-AGING & WRINKLE REDUCTION
  • 6.3 SKIN REPAIR & REGENERATION
  • 6.4 MOISTURIZING & HYDRATION
  • 6.5 WHITENING & BRIGHTENING
  • 6.6 HAIR CARE
  • 6.7 ANTI-INFLAMMATORY & SOOTHING

7 PEPTIDE COSMETIC API MARKET, BY SOURCE

  • 7.1 INTRODUCTION
  • 7.2 PLANT-DERIVED PEPTIDES
  • 7.3 ANIMAL-DERIVED PEPTIDES
  • 7.4 BIOENGINEERED PEPTIDES
  • 7.5 CHEMICALLY SYNTHESIZED

8 PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY

  • 8.1 INTRODUCTION
  • 8.2 SKINCARE
  • 8.3 HAIRCARE
  • 8.4 INJECTABLE COSMETICS
  • 8.5 OTHERS

9 PEPTIDE COSMETIC API MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 GERMANY
    • 9.3.2 UK
    • 9.3.3 FRANCE
    • 9.3.4 RUSSIA
    • 9.3.5 ITALY
    • 9.3.6 SPAIN
    • 9.3.7 REST OF EUROPE
  • 9.4 APAC
    • 9.4.1 CHINA
    • 9.4.2 INDIA
    • 9.4.3 JAPAN
    • 9.4.4 SOUTH KOREA
    • 9.4.5 MALAYSIA
    • 9.4.6 THAILAND
    • 9.4.7 INDONESIA
    • 9.4.8 REST OF APAC
  • 9.5 SOUTH AMERICA
    • 9.5.1 BRAZIL
    • 9.5.2 MEXICO
    • 9.5.3 ARGENTINA
    • 9.5.4 REST OF SOUTH AMERICA
  • 9.6 MEA
    • 9.6.1 GCC COUNTRIES
    • 9.6.2 SOUTH AFRICA
    • 9.6.3 REST OF MEA

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 MARKET SHARE ANALYSIS, 2023
  • 10.3 COMPETITOR DASHBOARD

11 COMPANY PROFILES

  • 11.1 DSM-FIRMENICH
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 TYPES OFFERED
    • 11.1.4 PATENT DETAILS
    • 11.1.5 PRODUCTION CAPACITY
    • 11.1.6 SALES VOLUME
    • 11.1.7 PRICING ANALYSIS
    • 11.1.8 SWOT ANALYSIS
    • 11.1.9 KEY STRATEGY
  • 11.2 BACHEM
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 TYPES OFFERED
    • 11.2.4 PATENT DETAILS
    • 11.2.5 PRODUCTION CAPACITY
    • 11.2.6 SALES VOLUME
    • 11.2.7 PRICING ANALYSIS
    • 11.2.8 SWOT ANALYSIS
    • 11.2.9 KEY STRATEGY
  • 11.3 LIPOTRUE SCIENCE
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 TYPES OFFERED
    • 11.3.3 PATENT DETAILS
    • 11.3.4 PRODUCTION CAPACITY
    • 11.3.5 SALES VOLUME
    • 11.3.6 PRICING ANALYSIS
    • 11.3.7 SWOT ANALYSIS
    • 11.3.8 KEY STRATEGY
  • 11.4 CRODA
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 TYPES OFFERED
    • 11.4.4 PATENT DETAILS
    • 11.4.5 PRODUCTION CAPACITY
    • 11.4.6 SALES VOLUME
    • 11.4.7 PRICING ANALYSIS
    • 11.4.8 SWOT ANALYSIS
    • 11.4.9 KEY STRATEGY
  • 11.5 CAREGEN
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 TYPES OFFERED
    • 11.5.3 PATENT DETAILS
    • 11.5.4 PRODUCTION CAPACITY
    • 11.5.5 SALES VOLUME
    • 11.5.6 PRICING ANALYSIS
    • 11.5.7 SWOT ANALYSIS
    • 11.5.8 KEY STRATEGY
  • 11.6 BASF SE
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 TYPES OFFERED
    • 11.6.4 PATENT DETAILS
    • 11.6.5 PRODUCTION CAPACITY
    • 11.6.6 SALES VOLUME
    • 11.6.7 PRICING ANALYSIS
    • 11.6.8 SWOT ANALYSIS
    • 11.6.9 KEY STRATEGY
  • 11.7 EVONIK INDUSTRIES AG
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 TYPES OFFERED
    • 11.7.4 PATENT DETAILS
    • 11.7.5 PRODUCTION CAPACITY
    • 11.7.6 SALES VOLUME
    • 11.7.7 PRICING ANALYSIS
    • 11.7.8 SWOT ANALYSIS
    • 11.7.9 KEY STRATEGY
  • 11.8 GIVAUDAN ACTIVE BEAUTY
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 TYPES OFFERED
    • 11.8.4 PATENT DETAILS
    • 11.8.5 PRODUCTION CAPACITY
    • 11.8.6 SALES VOLUME
    • 11.8.7 PRICING ANALYSIS
    • 11.8.8 SWOT ANALYSIS
    • 11.8.9 KEY STRATEGY
  • 11.9 ASHLAND GLOBAL HOLDINGS
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 TYPES OFFERED
    • 11.9.4 PATENT DETAILS
    • 11.9.5 PRODUCTION CAPACITY
    • 11.9.6 SALES VOLUME
    • 11.9.7 PRICING ANALYSIS
    • 11.9.8 SWOT ANALYSIS
    • 11.9.9 KEY STRATEGY
  • 11.10 SYMRISE AG
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 TYPES OFFERED
    • 11.10.4 PATENT DETAILS
    • 11.10.5 PRODUCTION CAPACITY
    • 11.10.6 SALES VOLUME
    • 11.10.7 PRICING ANALYSIS
    • 11.10.8 SWOT ANALYSIS
    • 11.10.9 KEY STRATEGY
  • 11.11 PROVITAL GROUP
    • 11.11.1 COMPANY OVERVIEW
    • 11.11.2 TYPES OFFERED
    • 11.11.3 PATENT DETAILS
    • 11.11.4 PRODUCTION CAPACITY
    • 11.11.5 SALES VOLUME
    • 11.11.6 PRICING ANALYSIS
    • 11.11.7 SWOT ANALYSIS
    • 11.11.8 KEY STRATEGY
  • 11.12 SPEC-CHEM INDUSTRY INC
    • 11.12.1 COMPANY OVERVIEW
    • 11.12.2 TYPES OFFERED
    • 11.12.3 PATENT DETAILS
    • 11.12.4 PRODUCTION CAPACITY
    • 11.12.5 SALES VOLUME
    • 11.12.6 PRICING ANALYSIS
    • 11.12.7 SWOT ANALYSIS
    • 11.12.8 KEY STRATEGY
  • 11.13 AMBIOPHARM
    • 11.13.1 COMPANY OVERVIEW
    • 11.13.2 TYPES OFFERED
    • 11.13.3 PATENT DETAILS
    • 11.13.4 PRODUCTION CAPACITY
    • 11.13.5 SALES VOLUME
    • 11.13.6 PRICING ANALYSIS
    • 11.13.7 SWOT ANALYSIS
    • 11.13.8 KEY STRATEGY
  • 11.14 LIPOTEC
    • 11.14.1 COMPANY OVERVIEW
    • 11.14.2 TYPES OFFERED
    • 11.14.3 PATENT DETAILS
    • 11.14.4 PRODUCTION CAPACITY
    • 11.14.5 SALES VOLUME
    • 11.14.6 PRICING ANALYSIS
    • 11.14.7 SWOT ANALYSIS
    • 11.14.8 KEY STRATEGY
  • 11.15 USV PRIVATE LIMITED
    • 11.15.1 COMPANY OVERVIEW
    • 11.15.2 TYPES OFFERED
    • 11.15.3 PATENT DETAILS
    • 11.15.4 PRODUCTION CAPACITY
    • 11.15.5 SALES VOLUME
    • 11.15.6 PRICING ANALYSIS
    • 11.15.7 SWOT ANALYSIS
    • 11.15.8 KEY STRATEGY
  • 11.16 CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH (CLR)
    • 11.16.1 COMPANY OVERVIEW
    • 11.16.2 TYPES OFFERED
    • 11.16.3 PATENT DETAILS
    • 11.16.4 PRODUCTION CAPACITY
    • 11.16.5 SALES VOLUME
    • 11.16.6 PRICING ANALYSIS
    • 11.16.7 SWOT ANALYSIS
    • 11.16.8 KEY STRATEGY
  • 11.17 ACTIVE PEPTIDE COMPANY
    • 11.17.1 COMPANY OVERVIEW
    • 11.17.2 TYPES OFFERED
    • 11.17.3 PATENT DETAILS
    • 11.17.4 PRODUCTION CAPACITY
    • 11.17.5 SALES VOLUME
    • 11.17.6 PRICING ANALYSIS
    • 11.17.7 SWOT ANALYSIS
    • 11.17.8 KEY STRATEGY
  • 11.18 SEIWA KASEI CO., LTD
    • 11.18.1 COMPANY OVERVIEW
    • 11.18.2 TYPES OFFERED
    • 11.18.3 PATENT DETAILS
    • 11.18.4 PRODUCTION CAPACITY
    • 11.18.5 SALES VOLUME
    • 11.18.6 PRICING ANALYSIS
    • 11.18.7 SWOT ANALYSIS
    • 11.18.8 KEY STRATEGY
  • 11.19 RS SYNTHESIS
    • 11.19.1 COMPANY OVERVIEW
    • 11.19.2 TYPES OFFERED
    • 11.19.3 PATENT DETAILS
    • 11.19.4 PRODUCTION CAPACITY
    • 11.19.5 SALES VOLUME
    • 11.19.6 PRICING ANALYSIS
    • 11.19.7 SWOT ANALYSIS
    • 11.19.8 KEY STRATEGY
  • 11.20 BCN PEPTIDES
    • 11.20.1 COMPANY OVERVIEW
    • 11.20.2 TYPES OFFERED
    • 11.20.3 PATENT DETAILS
    • 11.20.4 PRODUCTION CAPACITY
    • 11.20.5 SALES VOLUME
    • 11.20.6 PRICING ANALYSIS
    • 11.20.7 SWOT ANALYSIS
    • 11.20.8 KEY STRATEGY

LIST OF TABLES

  • TABLE 1 PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 2 PEPTIDE COSMETIC API MARKET, SOURCE, 2019-2035 (USD MILLION)
  • TABLE 3 PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 4 PEPTIDE COSMETIC API MARKET, BY REGION, 2019-2035 (USD MILLION)
  • TABLE 5 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY COUNTRY, 2019-2035 (USD MILLION)
  • TABLE 6 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 7 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 8 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 9 US: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 10 US: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 11 US: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 12 CANADA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 13 CANADA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 14 CANADA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 15 PEPTIDE COSMETIC API MARKET, FOR EUROPE, BY COUNTRY, 2019-2035 (USD MILLION)
  • TABLE 16 PEPTIDE COSMETIC API MARKET, FOR EUROPE , BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 17 PEPTIDE COSMETIC API MARKET, FOR EUROPE, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 18 PEPTIDE COSMETIC API MARKET, FOR EUROPE , BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 19 GERMANY: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 20 GERMANY: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 21 GERMANY: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 22 UK: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 23 UK: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 24 UK: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 25 FRANCE: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 26 FRANCE: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 27 FRANCE: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 28 RUSSIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 29 RUSSIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 30 RUSSIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 31 ITALY: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 32 ITALY: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 33 ITALY: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 34 SPAIN: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 35 SPAIN: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 36 SPAIN: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 37 REST OF EUROPE: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 38 REST OF EUROPE: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 39 REST OF EUROPE: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 40 PEPTIDE COSMETIC API MARKET, FOR APAC , BY COUNTRY, 2019-2035 (USD MILLION)
  • TABLE 41 PEPTIDE COSMETIC API MARKET, FOR APAC , BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 42 PEPTIDE COSMETIC API MARKET, FOR APAC , BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 43 PEPTIDE COSMETIC API MARKET, FOR APAC , BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 44 CHINA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 45 CHINA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 46 CHINA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 47 INDIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 48 INDIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 49 INDIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 50 JAPAN: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 51 JAPAN: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 52 JAPAN: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 53 SOUTH KOREA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 54 SOUTH KOREA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 55 SOUTH KOREA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 56 MALAYSIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 57 MALAYSIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 58 MALAYSIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 59 THAILAND: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 60 THAILAND: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 61 THAILAND: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 62 INDONESIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 63 INDONESIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 64 INDONESIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 65 REST OF APAC: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 66 REST OF APAC: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 67 REST OF APAC: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 68 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY COUNTRY, 2019-2035 (USD MILLION)
  • TABLE 69 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 70 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 71 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 72 BRAZIL: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 73 BRAZIL: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 74 BRAZIL: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 75 MEXICO: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 76 MEXICO: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 77 MEXICO: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 78 ARGENTINA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 79 ARGENTINA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 80 ARGENTINA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 81 REST OF SOUTH AMERICA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 82 REST OF SOUTH AMERICA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 83 REST OF SOUTH AMERICA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 84 PEPTIDE COSMETIC API MARKET, FOR MEA, BY COUNTRY, 2019-2035 (USD MILLION)
  • TABLE 85 PEPTIDE COSMETIC API MARKET, FOR MEA, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 86 PEPTIDE COSMETIC API MARKET, FOR MEA, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 87 PEPTIDE COSMETIC API MARKET, FOR MEA, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 88 GCC COUNTRIES: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 89 GCC COUNTRIES: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 90 GCC COUNTRIES: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 91 SOUTH AFRICA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 92 SOUTH AFRICA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 93 SOUTH AFRICA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 94 REST OF MEA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 95 REST OF MEA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 96 REST OF MEA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 97 DSM-FIRMENICH: PRODUCT OFFERED
  • TABLE 98 BACHEM: PRODUCT OFFERED
  • TABLE 99 LIPOTRUE SCIENCE: PRODUCT OFFERED
  • TABLE 100 CRODA: PRODUCT OFFERED
  • TABLE 101 CAREGEN: PRODUCT OFFERED
  • TABLE 102 BASF SE: PRODUCT OFFERED
  • TABLE 103 EVONIK INDUSTRIES AG: PRODUCT OFFERED
  • TABLE 104 GIVAUDAN ACTIVE BEAUTY: PRODUCT OFFERED
  • TABLE 105 ASHLAND GLOBAL HOLDINGS: PRODUCT OFFERED
  • TABLE 106 SYMRISE AG: PRODUCT OFFERED
  • TABLE 107 PROVITAL GROUP: PRODUCT OFFERED
  • TABLE 108 SPEC-CHEM INDUSTRY INC: PRODUCT OFFERED
  • TABLE 109 AMBIOPHARM: PRODUCT OFFERED
  • TABLE 110 LIPOTEC: PRODUCT OFFERED
  • TABLE 111 USV PRIVATE LIMITED: PRODUCT OFFERED
  • TABLE 112 CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH (CLR): PRODUCT OFFERED
  • TABLE 113 ACTIVE PEPTIDE COMPANY: PRODUCT OFFERED
  • TABLE 114 SEIWA KASEI CO., LTD: PRODUCT OFFERED
  • TABLE 115 RS SYNTHESIS: PRODUCT OFFERED
  • TABLE 116 BCN PEPTIDES: PRODUCT OFFERED

LIST OF FIGURES

  • FIGURE 1 PEPTIDE COSMETIC API MARKET: MARKET GROWTH FACTOR ANALYSIS (2019-2035)
  • FIGURE 3 SUPPLY CHAIN ANALYSIS: PEPTIDE COSMETIC API MARKET
  • FIGURE 5 PORTER'S FIVE FORCES MODEL: PEPTIDE COSMETIC API MARKET
  • FIGURE 6 PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2023 (% SHARE)
  • FIGURE 7 PEPTIDE COSMETIC API MARKET, BY SOURCE, 2023 (% SHARE)
  • FIGURE 8 PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2023 (% SHARE)
  • FIGURE 9 GLOBAL PEPTIDE COSMETIC API MARKET PLAYERS: COMPETITIVE ANALSIS, 2023
  • FIGURE 10 INDUSTRY CONCENTRATION, 2024
  • FIGURE 11 COMPETITOR DASHBOARD: GLOBAL MILITARY DRIVER VISION ENHANCER
  • FIGURE 12 DSM-FIRMENICH: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 13 DSM-FIRMENICH: SWOT ANALYSIS
  • FIGURE 14 BACHEM: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 15 BACHEM: SWOT ANALYSIS
  • FIGURE 16 LIPOTRUE SCIENCE: SWOT ANALYSIS
  • FIGURE 17 CRODA: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 18 CRODA: SWOT ANALYSIS
  • FIGURE 19 CAREGEN: SWOT ANALYSIS
  • FIGURE 20 BASF SE: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 21 BASF SE: SWOT ANALYSIS
  • FIGURE 22 EVONIK: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 23 EVONIK INDUSTRIES AG: SWOT ANALYSIS
  • FIGURE 24 GIVAUDAN ACTIVE BEAUTY: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 25 GIVAUDAN ACTIVE BEAUTY: SWOT ANALYSIS
  • FIGURE 26 ASHLAND GLOBAL HOLDINGS: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 27 ASHLAND GLOBAL HOLDINGS: SWOT ANALYSIS
  • FIGURE 28 SYMRISE AG: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 29 SYMRISE AG: SWOT ANALYSIS
  • FIGURE 30 PROVITAL GROUP: SWOT ANALYSIS
  • FIGURE 31 SPEC-CHEM INDUSTRY INC: SWOT ANALYSIS
  • FIGURE 32 AMBIOPHARM: SWOT ANALYSIS
  • FIGURE 33 LIPOTEC: SWOT ANALYSIS
  • FIGURE 34 USV PRIVATE LIMITED: SWOT ANALYSIS
  • FIGURE 35 CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH (CLR): SWOT ANALYSIS
  • FIGURE 36 ACTIVE PEPTIDE COMPANY: SWOT ANALYSIS
  • FIGURE 37 SEIWA KASEI CO., LTD: SWOT ANALYSIS
  • FIGURE 38 RS SYNTHESIS: SWOT ANALYSIS
  • FIGURE 39 BCN PEPTIDES: SWOT ANALYSIS